Diatheva is an Italian Biotech company based in Fano (Marche, IT) part of SOL Group, specialized in R&D and manufacturing of innovative diagnostic solutions and development of novel biologic therapeutics in oncology and infectious diseases areas. DIATHEVA is a Italian biotechnological company founded in 2002 with the aim to bring research into industrial products by cooperating with firms, public
and private research institutions. DIATHEVA focuses on development, production and marketing of new and innovative products (antibodies, recombinant proteins, immunoassays and SNPs detection kits) for diagnostics, research and therapeutic applications in the filed of: Cancer , Microbial Infection and Pharmacogenetics. DIATHEVA has a GMP authorized facility designed for the manufacture of APIs for pre-clinical and clinical trial studies with a special emphasis on new immunogens against HIV and other microbial pathogens. From 2009 DIATHEVA is a member of Marche BIOTECH and collaborates with the most important biotech companies in the Marche region extending its scientific network. From 2010 DIATHEVA provides a wide range of pharmacogenetic tests for personalized and predictive medicine based on High Resolution Melting technologies with priority focused on anti-tumoral treatments.
